W. Roth - Concepedia

Author

W. Roth

Boehringer Ingelheim (Germany)ORCID

Also Known As

W Roth, W. Roth, Winter R Roth, Winter R. Roth, Winter Roth

Publications

828

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Germany)Pharmazeutische Fabrik Dr. Reckeweg (Germany)

About

W. Roth is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacokinetics, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	332
2	Allergy	1	1	252
3	Anesthesia	1	1	23
4	Biochemistry	1	1	18
5	Gastroenterology	1	1	23

W. Roth

Publications

581

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics of meloxicam in animals and the relevance to humans. Ulrich Busch, Jochen Schmid, G. Heinzel, PubMed InflammationPharmacokinetic ModelingAllergyPharmacokinetic ProfileMedicine	1998	252
Pharmacokinetics of Orally and Intravenously Administered Telmisartan in Healthy Young and Elderly Volunteers and in Hypertensive Patients Joachim Stangier, CAPF Su, W. Roth Journal of International Medical Research	2000	208
Zatebradine: Pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects W. Roth, Emily Bauer, G. Heinzel, Journal of Pharmaceutical Sciences Intravenous InfusionHealthy SubjectsCardiovascular DiseasePharmacologyCardiovascular Pharmacology	1993	25
Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to man Andreas Leusch, Wolfgang Tröger, Andreas Greischel, Xenobiotica	2000	25
[Pharmacokinetics and laxative effect of bisacodyl following administration of various dosage forms]. W. Roth, K Beschke PubMed Medicinal ChemistryDeconjugated BhpmPharmacokinetic ModelingPharmacological StudyPhysiology	1988	23
Fully-automated assay by liquid chromatography for routine drug monitoring in body fluids — method development with biological samples W. Roth, K Beschke Journal of Pharmaceutical and Biomedical Analysis BiochemistryRoutine Drug MonitoringBioanalysisPharmacologyDrug Testing	1984	18
Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic W. Roth, Mitchell Tam, Carrie Bi, Clinical Toxicology	2021	16
Pharmacokinetic profile and tolerability of pimobendan in patients with terminal renal insufficiency M. Przechera, W. Roth, Volker K�hlkamp, European Journal of Clinical Pharmacology Renal FunctionPharmacokinetic ProfileKidney FailureChronic Kidney DiseasePharmacology	1991	14

Page 1